Multi-level profiling of the Fmr1 KO rat unveils altered behavioral traits along with aberrant glutamatergic function
Authors:
- Katerina AntoniouKAKaterina Antoniou
- Charalampos BrakatselosCBCharalampos Brakatselos
- Foteini DelisFDFoteini Delis
- Leonidas LeontiadisLLLeonidas Leontiadis
- George TrompoukisGTGeorge Trompoukis
- Costas PapatheodoropoulosCPCostas Papatheodoropoulos
- Dimitrios GkikasDGDimitrios Gkikas
- Dimitrios ValakosDVDimitrios Valakos
- Giannis VatsellasGVGiannis Vatsellas
Preprint
- 24 July 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Fragile X Syndrome (FXS) is the most common cause of inherited intellectual disabilities and the most prevalent monogenic cause of autism. Although the knockout (KO) of the Fmr1 gene homolog in mice is primarily used for elucidating the neurobiological substrate of FXS, there is limited association of the experimental data with the pathophysiological condition in humans. The use of Fmr1 KO rats offers additional translational validity in this regard. Therefore, we employed a multi-level approach to study the behavioral profile and the glutamatergic and GABAergic neurotransmission status in pathophysiology-associated brain structures of Fmr1 KO rats, including the recordings of evoked and spontaneous field potentials from hippocampal slices, paralleled with next generation RNA sequencing (RNA-seq). We found that these rats exhibit hyperactivity and cognitive deficits, along with characteristic bidirectional glutamatergic and GABAergic alterations in the prefrontal cortex and the hippocampus. These results are coupled to affected excitability and local inhibitory processes in the hippocampus, along with a specific transcriptional profile, highlighting dysregulated hippocampal network activity in KO rats. Overall, our data provide novel insights concerning the biobehavioral profile of FmR1 KO rats and translationally upscales our understanding on pathophysiology and symptomatology of FXS syndrome.Keywords
All Related Versions
- Version 1, 2023-07-24, Research Square
- Published version: Translational Psychiatry, 14 (1), 1.
This publication has 67 references indexed in Scilit:
- Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndromePsychopharmacology, 2022
- Psychoactive properties of BNN27, a novel neurosteroid derivate, in male and female ratsPsychopharmacology, 2020
- Metformin treatment in young children with fragile X syndromeMolecular Genetics & Genomic Medicine, 2019
- Autism‐associated Shank3 mutations alter mGluR expression and mGluR‐dependent but not NMDA receptor‐dependent long‐term depressionSynapse, 2019
- Functional Neurochemistry of the Ventral and Dorsal Hippocampus: Stress, Depression, Dementia and Remote Hippocampal DamageNeurochemical Research, 2018
- SHANK3 as an autism spectrum disorder-associated geneBrain and Development, 2013
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and AutismCell, 2011
- The Fragile X Syndrome Protein Represses Activity-Dependent Translation through CYFIP1, a New 4E-BPCell, 2008
- A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral dataBehavioural Brain Research, 1988
- Primary Cultures of Gabaergic and Glutamatergic Neurons as Model Systems to Study Neurotransmitter Functions I. Differentiated Cells1987